<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
	<title>Cyberounds Online CME</title>
	<link>http://www.cyberounds.com/</link>
	<description>The latest online CME activities from Cyberounds</description>
	<atom:link href="http://www.cyberounds.com/feed/rss.xml" rel="self" type="application/rss+xml" />


<item>
	<title>Current Management of Obesity</title>
	<link>http://www.cyberounds.com/cmecontent/art468.html</link>
	<description>Conference Objectives: 1)Describe the epidemiologic trends of overweight and obesity in the United States2)Explain the etiology of overweight and obesity3)Perform the medical and nutritional assessment of overweight and obese patients4)Apply the medical, nutritional and lifestyle approaches for management of overweight and obese patients.</description>
	<guid>http://www.cyberounds.com/cmecontent/art468.html</guid>
	<pubDate>Mon, 01 Mar 2010 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Molecularly Targeted Therapy for Malignant Brain Tumors</title>
	<link>http://www.cyberounds.com/cmecontent/art467.html</link>
	<description>Conference Objectives: 1)Highlight pathways important in gliomagenesis2)Discuss the current use of molecularly targeted agents for gliomas, as well as efficacy and adverse effects of treatment3)Discuss the ongoing research using targeted agents in the treatment of gliomas.</description>
	<guid>http://www.cyberounds.com/cmecontent/art467.html</guid>
	<pubDate>Mon, 22 Feb 2010 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Neuropathic Complications of Diabetes</title>
	<link>http://www.cyberounds.com/cmecontent/art459.html</link>
	<description>Conference Objectives: 1)Apply our current understanding of the symptoms and signs associated with the neurologic complications of diabetes to assess the potential for development or the presence of a diabetes-associated neuropathy2)Describe the endocrine, metabolic and physiological derangements associated with neurological complications of diabetes3)Apply the knowledge of the symptoms, signs and pathophysiology of diabetic neuropathies to select the appropriate diagnostic and therapeutic intervention(s).</description>
	<guid>http://www.cyberounds.com/cmecontent/art459.html</guid>
	<pubDate>Mon, 01 Feb 2010 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Cell and Molecular Biology of Aging</title>
	<link>http://www.cyberounds.com/cmecontent/art464.html</link>
	<description>Conference Objectives: 1)Define characteristics of cellular aging2)List the key mechanisms responsible for cell senescence3)Discuss the relationship between cell aging in vitro and in vivo4)Describe the relationship between cell senescence and age-related diseases.</description>
	<guid>http://www.cyberounds.com/cmecontent/art464.html</guid>
	<pubDate>Mon, 11 Jan 2010 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Containing Health Care Costs</title>
	<link>http://www.cyberounds.com/cmecontent/art465.html</link>
	<description>Conference Objectives: 1)Describe why health care is so expensive in the United States relative to other industrialized countries 2)Describe approaches that could reduce health care spending 3)Describe which of these approaches are more and which are less likely to be adopted.</description>
	<guid>http://www.cyberounds.com/cmecontent/art465.html</guid>
	<pubDate>Tue, 15 Dec 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Blunt Abdominal Trauma: Current Concepts</title>
	<link>http://www.cyberounds.com/cmecontent/art451.html</link>
	<description>Conference Objectives: 1)Discuss the current role of ultrasonography (FAST) in the triage of blunt trauma patients.2)Discuss the interpretation of abnormal findings on FAST and implications.3)Discuss the therapeutic approaches to managing patients with blunt abdominal injuries and their disposition.4)Discuss the diagnostic options in subgroups such as pregnant, obese, and pediatric patients.</description>
	<guid>http://www.cyberounds.com/cmecontent/art451.html</guid>
	<pubDate>Mon, 16 Nov 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>The Indigenous Gastrointestinal Microbiota in Health and Disease</title>
	<link>http://www.cyberounds.com/cmecontent/art463.html</link>
	<description>Conference Objectives: 1)Discuss the importance of the indigenous gastrointestinal microbiota in gut health and disease2)Identify new technologies for studying the indigenous microbiota3)Discuss how therapeutic manipulation of the microbiota may represent a novel means to prevent and treat GI disease.</description>
	<guid>http://www.cyberounds.com/cmecontent/art463.html</guid>
	<pubDate>Mon, 26 Oct 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Nephrogenic Systemic Fibrosis</title>
	<link>http://www.cyberounds.com/cmecontent/art462.html</link>
	<description>Conference Objectives: 1)Discuss the use of gadolinium as contrast media for MRI2)Assess the risk factors for developing nephrogenic systemic fibrosis when considering use of MRI in patients with renal failure3)Describe the clinical presentation and biopsy findings in nephrogenic systemic fibrosis.</description>
	<guid>http://www.cyberounds.com/cmecontent/art462.html</guid>
	<pubDate>Mon, 12 Oct 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Treatment-resistant Depression in Adolescents: Assessment and Management</title>
	<link>http://www.cyberounds.com/cmecontent/art461.html</link>
	<description>Conference Objectives: 1)Provide definitions of adequate treatment and treatment-resistant depression2)Present a guide to the assessment of the adolescent with treatment- resistant depression3)Describe a treatment approach to the adolescent with treatment-resistant depression.</description>
	<guid>http://www.cyberounds.com/cmecontent/art461.html</guid>
	<pubDate>Mon, 21 Sep 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Hemophagocytic Syndrome in Rheumatic Diseases</title>
	<link>http://www.cyberounds.com/cmecontent/art457.html</link>
	<description>Conference Objectives: 1)Define the hemophagocytic syndrome (HPS)2)List the rheumatic diseases that have been associated with reactive HPS 3)Describe the clinical and lab manifestations of this disorder4)Discuss the life-saving treatments that should be considered early when autoimmune-associated hemophagocytic syndrome (AAHS) is suspected.</description>
	<guid>http://www.cyberounds.com/cmecontent/art457.html</guid>
	<pubDate>Mon, 10 Aug 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Infections in Long-term Care Facilities: &lt;br /&gt;Epidemiology, Diagnosis and Prevention </title>
	<link>http://www.cyberounds.com/cmecontent/art460.html</link>
	<description>Conference Objectives: 1)Describe risk factors and epidemiology of common infections in long-term care facility residents2)List diagnostic criteria for infections in patients with a paucity of symptoms3)Implement strategies to prevent common infections in long-term care facility residents.</description>
	<guid>http://www.cyberounds.com/cmecontent/art460.html</guid>
	<pubDate>Tue, 21 Jul 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>The Role of Matrix Metalloproteinases (MMPs) in COPD</title>
	<link>http://www.cyberounds.com/cmecontent/art456.html</link>
	<description>Conference Objectives: 1)List the pathologic features of chronic bronchitis and emphysema2)Discuss whether MMPs contribute to the development of COPD3)Discuss if MMP inhibitors might effectively treat or prevent COPD.</description>
	<guid>http://www.cyberounds.com/cmecontent/art456.html</guid>
	<pubDate>Mon, 29 Jun 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Genetic Variation In Taste Receptors and Eating Behavior</title>
	<link>http://www.cyberounds.com/cmecontent/art458.html</link>
	<description>Conference Objectives: 1)Describe behaviors associated with genetic variation in taste receptors2)Identify the receptor type most commonly associated with ingestive behavior3)Identify individuals whose eating behavior is likely to be most influenced by genetic variation in taste receptors4)Identify biologic processes involved in taste receptor modulation of eating behavior.</description>
	<guid>http://www.cyberounds.com/cmecontent/art458.html</guid>
	<pubDate>Mon, 08 Jun 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Glucose Sensing in the Central Nervous System</title>
	<link>http://www.cyberounds.com/cmecontent/art453.html</link>
	<description>Conference Objectives: 1)Identify the sites in the brain that sense and respond to changes in blood sugar 2)Identify some of the key glucose sensing proteins in the brain3)Describe the hierarchy of hormones that are released in response to hypoglycemia 4)Discuss the etiology of the impaired counterregulatory response and hypoglycemia unawareness that occurs in people with diabetes 5)List some therapeutic interventions shown to reduce the risk of hypoglycemia.</description>
	<guid>http://www.cyberounds.com/cmecontent/art453.html</guid>
	<pubDate>Tue, 12 May 2009 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Direct-To-Consumer Genetic Testing</title>
	<link>http://www.cyberounds.com/cmecontent/art455.html</link>
	<description>Conference Objectives: 1)List the benefits and detriments of direct-to-consumer genetic testing2)Discuss the ethical and legal problems that direct-to-consumer genetic testing may create for caregivers3)Describe steps that caregivers might take to respond to these ethical and legal problems.</description>
	<guid>http://www.cyberounds.com/cmecontent/art455.html</guid>
	<pubDate>Tue, 28 Apr 2009 16:00:00 GMT </pubDate>
</item>

</channel>
</rss>
